| abstract |
The present invention relates to purified 3-methanesulfonylpropionitrile or its pharmaceutically acceptable salts, and to a method for the preparation of said compound. The compound has a purity of at least 90% (w / w). The present invention is also directed to a pharmaceutical composition comprising the purified compound and a pharmaceutically acceptable carrier. The present invention is further directed to a method for the treatment of inflammation, disorders related to inflammation, or pain, by the administration of 3-methanesulfonylpropionitrile or its pharmaceutically acceptable salts or solvates, to a patient who requires it. |